187 related articles for article (PubMed ID: 21378451)
21. Differences in the microcirculation disturbance in the right and left ventricles of neonatal rats with hypoxic pulmonary hypertension.
Yang L; Cao J; Ma J; Li M; Mu Y
Microvasc Res; 2021 May; 135():104129. PubMed ID: 33385381
[TBL] [Abstract][Full Text] [Related]
22. Nitrendipine attenuates the pulmonary vascular remodeling and right ventricular hypertrophy caused by intermittent hypoxia in rats.
Michael JR; Kennedy TP; Buescher P; Farrukh I; Lodato R; Rock PC; Gottlieb J; Gurtner G; de la Monte SM; Hutchins GM
Am Rev Respir Dis; 1986 Mar; 133(3):375-9. PubMed ID: 2937355
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor expression in heart of rats exposed to hypobaric hypoxia: differential response between mRNA and protein.
Birot OJ; Peinnequin A; Simler N; van Cuyck-Gandré H; Hamel R; Bigard XA
J Cell Physiol; 2004 Jul; 200(1):107-15. PubMed ID: 15137063
[TBL] [Abstract][Full Text] [Related]
24. Magnesium lithospermate B ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and its potential targets.
Wang Y; Duo D; Yan Y; He R; Wu X
Biomed Pharmacother; 2020 Oct; 130():110560. PubMed ID: 34321157
[TBL] [Abstract][Full Text] [Related]
25. Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice.
Levi M; Moons L; Bouché A; Shapiro SD; Collen D; Carmeliet P
Circulation; 2001 Apr; 103(15):2014-20. PubMed ID: 11306532
[TBL] [Abstract][Full Text] [Related]
26. Induction of cardiac natriuretic peptide gene expression in rats trained in hypobaric hypoxic conditions.
Perhonen M; Takala TE; Vuolteenaho O; Mäntymaa P; Leppäluoto J; Ruskoaho H
Am J Physiol; 1997 Jul; 273(1 Pt 2):R344-52. PubMed ID: 9249570
[TBL] [Abstract][Full Text] [Related]
27. MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension.
Brown RD; Ambler SK; Li M; Sullivan TM; Henry LN; Crossno JT; Long CS; Garrington TP; Stenmark KR
Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H269-81. PubMed ID: 23125215
[TBL] [Abstract][Full Text] [Related]
28. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.
Xia S; Tai X; Wang Y; An X; Qian G; Dong J; Wang X; Sha B; Wang D; Murthi P; Kalionis B; Wang X; Bai C
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044
[TBL] [Abstract][Full Text] [Related]
29. Solnatide Demonstrates Profound Therapeutic Activity in a Rat Model of Pulmonary Edema Induced by Acute Hypobaric Hypoxia and Exercise.
Zhou Q; Wang D; Liu Y; Yang X; Lucas R; Fischer B
Chest; 2017 Mar; 151(3):658-667. PubMed ID: 27815150
[TBL] [Abstract][Full Text] [Related]
30. Capillary Degeneration and Right Ventricular Remodeling Due to Hypoxic Stress with Sugen5416.
Woo E; Kato R; Imano H; Fujiwara Y; Ijiri Y; Okada Y; Yamaguchi T; Izumi Y; Yoshiyama M; Katsumata T; Hayashi T
Curr Vasc Pharmacol; 2017; 15(6):589-598. PubMed ID: 28460626
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-inducible factor-1 alpha regulates the role of vascular endothelial growth factor on pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.
Li QF; Dai AG
Chin Med J (Engl); 2004 Jul; 117(7):1023-8. PubMed ID: 15265376
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Chronic Intermittent Hypobaric Hypoxia in Rats Causes an Imbalance in the Asymmetric Dimethylarginine/Nitric Oxide Pathway and ROS Activity: A Possible Synergistic Mechanism for Altitude Pulmonary Hypertension?
Lüneburg N; Siques P; Brito J; Arriaza K; Pena E; Klose H; Leon-Velarde F; Böger RH
Pulm Med; 2016; 2016():6578578. PubMed ID: 27313889
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of vasonatrin peptide against hypobaric hypoxia-induced pulmonary hypertension in rats.
Yu J; Feng HS; Chen BY; Qu P; Liu LB; Chen JK; Tie R; Huang XJ; Zhao YF; Zhu XX; Zhu MZ
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):69-74. PubMed ID: 19566831
[TBL] [Abstract][Full Text] [Related]
34. Changes in myosin heavy chain and its localization in rat heart in association with hypobaric hypoxia-induced pulmonary hypertension.
Nakanishi K; Nakata Y; Kanazawa F; Imamura S; Matsuoka R; Osada H; Kawai T; Uenoyama M; Aurues T; Ikeda T
J Pathol; 2002 Jul; 197(3):380-7. PubMed ID: 12115885
[TBL] [Abstract][Full Text] [Related]
35. Physiopathological implications of P2X
Franco M; Bautista-Pérez R; Cano-Martínez A; Pacheco U; Santamaría J; Del Valle Mondragón L; Pérez-Méndez O; Navar LG
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F9-F19. PubMed ID: 28404593
[TBL] [Abstract][Full Text] [Related]
36. Cyclosporin A inhibits hypoxia-induced pulmonary hypertension and right ventricle hypertrophy.
Koulmann N; Novel-Chaté V; Peinnequin A; Chapot R; Serrurier B; Simler N; Richard H; Ventura-Clapier R; Bigard X
Am J Respir Crit Care Med; 2006 Sep; 174(6):699-705. PubMed ID: 16799071
[TBL] [Abstract][Full Text] [Related]
37. Developmental pattern of ventricular atrial natriuretic peptide (ANP) expression in chronically hypoxic rats as an indicator of the hypertrophic process.
McKenzie JC; Kelley KB; Merisko-Liversidge EM; Kennedy J; Klein RM
J Mol Cell Cardiol; 1994 Jun; 26(6):753-67. PubMed ID: 8089855
[TBL] [Abstract][Full Text] [Related]
38. Salubrinal attenuates right ventricular hypertrophy and dysfunction in hypoxic pulmonary hypertension of rats.
He YY; Liu CL; Li X; Li RJ; Wang LL; He KL
Vascul Pharmacol; 2016 Dec; 87():190-198. PubMed ID: 27678416
[TBL] [Abstract][Full Text] [Related]
39. Expression and Correlation of Hypoxia-Inducible Factor-1α (HIF-1α) with Pulmonary Artery Remodeling and Right Ventricular Hypertrophy in Experimental Pulmonary Embolism.
Liu W; Zhang Y; Lu L; Wang L; Chen M; Hu T
Med Sci Monit; 2017 May; 23():2083-2088. PubMed ID: 28459801
[TBL] [Abstract][Full Text] [Related]
40. Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.
Desbuards N; Antier D; Rochefort GY; Apfeldorfer CS; Schenck E; Hanton G; Hyvelin JM
Eur J Pharmacol; 2009 Jan; 602(2-3):355-63. PubMed ID: 19049806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
